Seminars in Nuclear Medicine
Volume 32, Issue 2 , Pages 97-109, April 2002

Cholecystokinin-B/gastrin receptor-targeting peptides for staging and therapy of medullary thyroid cancer and other cholecystokinin-B receptor-expressing malignancies

  • Thomas M. Behr

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Thomas M. Behr, MD, Department of Nuclear Medicine, Philipps-University of Marburg, Baldingerstr., D-35043 Marburg/Lahn, Germany
    • ,
  • Martin P. Béhé

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0001-2998(02)80028-9

doi:10.1053/snuc.2002.31028

Seminars in Nuclear Medicine
Volume 32, Issue 2 , Pages 97-109, April 2002

Article Tools